NeuralCipher Source record
[Parkinson's disease: from genetics to targeted therapies].
DOI: 10.5802/crbiol.174PMID: 39945455
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
106.961 articles found
Open access
Smartphone Application-Based Voice and Speech Training Program for Parkinson Disease: Feasibility and Satisfaction Study With a Preliminary Rater-Blinded Single-Arm Pretest and Posttest Design.
DOI: 10.2196/63166PMID: 39946689
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Effects of a Rosiridin against Rotenone-induced Rats' Model of Parkinson's Disease: In-vivo Study and in silico Molecular Modeling.
DOI: 10.2174/011570159x349553250126050134PMID: 39949093
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Chemosensory Impairments and Their Impact on Nutrition in Parkinson's Disease: A Narrative Literature Review.
DOI: 10.3390/nu17040671PMID: 40004999
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Corrigendum to "Neurogranin binds alpha-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease" [Brain Res. 1591 (2014) 102-110].
DOI: 10.1016/j.brainres.2025.149504PMID: 39947974
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease.
DOI: 10.1016/j.stem.2025.01.006PMID: 39952239
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Improving reliability of movement assessment in Parkinson's disease using computer vision-based automated severity estimation.
DOI: 10.1177/1877718x241312605PMID: 39973505
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease.
DOI: 10.1016/j.nbd.2025.106841PMID: 39954745
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Outlook of SNCA (α-synuclein) transgenic fly models in delineating the sequel of mitochondrial dysfunction in Parkinson's disease.
DOI: 10.1016/j.brainres.2025.149505PMID: 39954798
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
The alteration of glutamate involved in the brain of Parkinson's disease patients using glutamate chemical exchange saturation transfer (GluCEST).
DOI: 10.1016/j.bbr.2025.115484PMID: 39955039
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease.
DOI: 10.1002/mds.30148PMID: 39945211
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Impact of pharmacist-physician collaboration on patient outcomes in Parkinson's disease: a randomised controlled trial in tertiary care.
DOI: 10.1007/s11096-025-01883-6PMID: 39945968
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.